U.S. market Closed. Opens in 11 hours 50 minutes

AURA | Aura Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue1.29M1.18M835.00K831.00K509.00K
Gross Profit-1.29M-1.18M-835.00K-831.00K-509.00K
Operating Expenses83.70M60.30M35.25M22.21M24.14M
Selling, General & Admin19.76M18.06M10.09M4.16M4.52M
Research & Development63.94M42.24M25.16M18.04M19.62M
Other Operating ExpensesN/A-5.00K-11.00K3.00K-44.00K
Operating Income-84.99M-60.30M-35.25M-22.21M-24.14M
Other Expenses / Income8.72M1.53M-1.00K3.00K-60.00K
Before Tax Income-76.27M-58.76M-35.25M-22.21M-24.20M
Income Tax Expenses137.00K-1.53M-830.00K3.00K5.00K
Net Income-76.41M-57.23M-34.42M-22.21M-24.20M
Interest ExpensesN/A-850.00K13.00K3.00K5.00K
Basic Shares Outstanding39.62M29.94M29.21M29.22M29.22M
Diluted Shares Outstanding39.62M29.94M29.21M29.22M29.22M
EBITDA-83.70M-59.97M-35.24M-21.38M-23.63M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-76.27M-59.61M-35.24M-22.20M-24.20M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙